Year 2004 2006 2008 2010 2012 2014 2015 2016
Wave 1 2 3 4 5 6 CheckPoint 7
Age 3-19 months 2-3 years 4-5 years 6-7 years 8-9 years 10-11 years 11-12 years 12-13 years
Biomarker analysis
(urine, albumin and creatinine,
albumin-to-creatinine ratio) 1
Metabolic profile
(serum, Nightingale 2017 panel) 2


1 Albumin and creatinine were quantified in urine to assess for albuminuria. A Cobas Integra® 400 plus analyzer, determining albumin using an immunoturbimetric assay (ALBT2 kit, Test ID 0-171, Roche Diagnostics, Germany), and creatinine using the enzymatic colorimetric method (Creatinine plus version2 CREP2U kit, Test ID 0-512, Roche Diagnostics, Germany). Laboratory work undertaken at the Baker Heart and Diabetes Institute (Melbourne, Australia) in 2016
2 The Nightingale® Nuclear Magnetic Resonance (NMR) metabolomics platform was used to quantify 288 metabolic biomarkers from 0.35mL of serum using the 2017 version quantification of Nightingale’s algorithm ( Key variables include total cholesterol, LDL cholesterol, HDL cholesterol, total triglycerides, glucose, glycoprotein acetyls, apolipoprotein A1 (apoA1), and apolipoprotein B (apoB)


A = Administration report abstraction
C = Index child report (reporting on others)
L = Linkage (to other databases)
M = Medical records data abstraction
O = Observation/direct assessment
N = Nurse report
P = Parent/primary caregiver report
Pe = Peer report
S = Self report
T = Teacher report
X = Undefined
X BF = Pertaining to biological father
X BM = Pertaining to biological mother
C = Pertaining to index child
X F = Pertaining to father
X Fam = Pertaining to family
X G = Pertaining to grandparent(s)
X M = Pertaining to mother
X P = Pertaining to parent(s)
X Pa = Pertaining to partner
X Pe = Pertaining to peers
X Pr = Pertaining to primary caregiver
X Si = Pertaining to sibling(s)